{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T05:36:09Z","timestamp":1741152969904,"version":"3.38.0"},"reference-count":16,"publisher":"SAGE Publications","issue":"21_suppl","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Urologia"],"published-print":{"date-parts":[[2013,1]]},"abstract":"<jats:p> A shortage of BCG is foreseen till the end of 2013. <\/jats:p><jats:p> Which will be the management of intermediate and high-risk NMI-BC if BCG will not be available? In patients harboring high-risk NMI tumors, particularly T1G3 and Tis, the first therapeutic choice is radical cystectomy. Device-assisted therapies, although showing promising results, should be considered only for selected patients. <\/jats:p><jats:p> In intermediate risk patients, intravesical chemotherapy remains a legitimate option even if BCG is available. Thus, in a period of BCG shortage, intravesical chemotherapy should be offered, preferably preceded by early instillation, according to the EAU guidelines. <\/jats:p>","DOI":"10.5301\/ru.2013.10860","type":"journal-article","created":{"date-parts":[[2013,5,10]],"date-time":"2013-05-10T06:01:19Z","timestamp":1368165679000},"page":"24-26","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Endovesical Treatment as an Alternative to BCG for Intermediate or High-Risk NMI Bladder Cancer"],"prefix":"10.1177","volume":"80","author":[{"given":"Vincenzo","family":"Serretta","sequence":"first","affiliation":[{"name":"Sezione di Urologia, Dipartimento di Discipline Chirurgiche ed Oncologiche, Universit\u00e0 degli Studi di Palermo - Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renzo","family":"Colombo","sequence":"additional","affiliation":[{"name":"Dipartimento di Urologia - Universit\u00e0 \u201cVita Salute San Raffaele\u201d Milano - Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2013,3,22]]},"reference":[{"journal-title":"Eur Urol.","year":"2012","author":"Oddens J.","key":"bibr1-RU.2013.10860"},{"key":"bibr2-RU.2013.10860","first-page":"677","volume":"57","author":"Sylvester R.J.","year":"2010","journal-title":"Urol"},{"key":"bibr3-RU.2013.10860","first-page":"399","volume":"45","author":"Gattegno B.","year":"2004","journal-title":"Conservative Management or Cystectomy? Eur Urol"},{"key":"bibr4-RU.2013.10860","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2006.08.070"},{"key":"bibr5-RU.2013.10860","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2007.06.030"},{"key":"bibr6-RU.2013.10860","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(01)65396-5"},{"key":"bibr7-RU.2013.10860","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-4356(99)00203-6"},{"key":"bibr8-RU.2013.10860","doi-asserted-by":"publisher","DOI":"10.1097\/01.ju.0000125486.92260.b2"},{"key":"bibr9-RU.2013.10860","doi-asserted-by":"publisher","DOI":"10.1097\/01.ju.0000100386.07370.0a"},{"key":"bibr10-RU.2013.10860","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2007.02.063"},{"key":"bibr11-RU.2013.10860","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2003.11.049"},{"key":"bibr12-RU.2013.10860","doi-asserted-by":"publisher","DOI":"10.1097\/01.COC.0000026911.98171.C6"},{"key":"bibr13-RU.2013.10860","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2009.04.038"},{"key":"bibr14-RU.2013.10860","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2009.04.043"},{"key":"bibr15-RU.2013.10860","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2009.04.041"},{"key":"bibr16-RU.2013.10860","unstructured":"BabjukM., OosterlinckW., SylvesterR. EAU Guidelines on Non-Muscle-Invasive Urothelial Carcinoma of the Bladder. At: http:\/\/www.uroweb.org\/gls\/pdf\/05_TaT1_Bladder_Cance."}],"container-title":["Urologia Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.5301\/RU.2013.10860","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.5301\/RU.2013.10860","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.5301\/RU.2013.10860","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T12:08:26Z","timestamp":1741090106000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.5301\/RU.2013.10860"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":16,"journal-issue":{"issue":"21_suppl","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["10.5301\/RU.2013.10860"],"URL":"https:\/\/doi.org\/10.5301\/ru.2013.10860","relation":{},"ISSN":["0391-5603","1724-6075"],"issn-type":[{"type":"print","value":"0391-5603"},{"type":"electronic","value":"1724-6075"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}